Drug Type T-lymphocyte cell therapy |
Synonyms LG-723 |
Target |
Action stimulants |
Mechanism melan-A stimulants(Melanoma antigen recognized by T-cells 1 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 1 | United States | - | |
Melanoma | Phase 1 | United States | - |